Have you heard the buzz about GLP-1/GIPs for weight loss and improving blood glucose outcomes? Did you know the GLP-1/GIP medications currently available are only approved for use in people with T2D or obesity? If you are living with T1D and looking to lose weight, you may be eligible for a clinical trial evaluating a new GLP-1/GIP specifically designed to support weight loss and glucose management in those with T1D. Visit the study page to learn more and to answer a few questions to see if you may be eligible. https://hubs.ly/Q02qbsK20 #type1diabetes #t1d #weightloss #GLP1
T1D Exchange’s Post
More Relevant Posts
-
Beyond Diabetes Management: Embracing the Power of SGLT2 Inhibitors and GLP1-RA! Did you know these game-changers aren't just for #diabetes? Explore how these drugs are rewriting the narrative for #ASCVD, #CKD, #heartfailure, and weight loss and elevating patient care across the spectrum. To learn how to incorporate these drugs into your practice, visit a pharmacist today! https://lnkd.in/d3gpvbQ #MedicalAdvancements #HeartHealth #BeyondDiabetes #HealthInnovation
To view or add a comment, sign in
-
Clinical Pharmacologist Intern @ Kokilaben Hospital | Medication Safety & Management Expert | Clinical Decisions | Interdisciplinary Collab | Personalized Care
High-Risk Medications: Why Monitoring is Crucial ? Some medications need careful monitoring to ensure they're safe and effective. Here are a few examples: 💊 Warfarin: Prevents blood clots but increases bleeding risk. Monitor INR levels. 💊 Digoxin: Treats heart conditions but can be toxic. Monitor digoxin levels, renal function, and electrolytes. 💊 Lithium: Stabilizes mood in bipolar disorder but can be toxic. Monitor lithium levels, renal, and thyroid function. 💊 Insulin: Manages diabetes but needs careful dosing. Monitor blood glucose and A1C levels. 💊 Methotrexate: Treats cancer and autoimmune diseases but can be toxic. Monitor CBC, liver, and renal function. Regular monitoring of these medications is essential to stay safe and healthy. Learn more in our latest video! 🎥👇 #pharmacy #healthcare #pharmd #patientcare #healthtips
To view or add a comment, sign in
-
Today we decided to take a look at the price of Ozempic. The current shortage has been driven by the increase in demand as the drug is being used to treat obese patients for long term weight management, in addition to the original group of type 2 diabetes patients. A study run by the University College London (UCL), lead by Professor John Deanfield, with over 17,604 patients has already shown heart benefits. Semaglutide could have a positive impact on blood pressure or inflammation, as well as direct effects on the heart muscle and vessels. Whilst this could be positive news for those suffering with cardiovascular health challenges, it does leave those type 2 diabetes patients prescribed Ozempic, and struggling to get hold of their medication, wondering how long the shortage will last and how the manufacturer will manage another potential increase in demand. Note all prices are those offered to UK Pharmacies or Dispensing Doctors. #ozempic #ukdrugshortages #ukpharmpricing
To view or add a comment, sign in
-
Discover the game-changer in diabetes treatment - Glucagon-like peptide-1 (GLP-1) agonists. Why are GLP-1 agonists gaining traction? 1. Effective Blood Sugar Control 2. Weight Management 3. Possible Heart Health Benefits With great power comes the need for safety and expertise. These medications are prevalent in the news media and Pharmacy Benefit Management (PBM) industry, emphasizing the crucial role of pharmacists in ensuring patient safety. Contact us to learn more about how we manage GLP-1s for our members. https://lnkd.in/e_YsE5yt #GLP1Agonists #DiabetesManagement #PatientSafety #PharmacyInnovation #PBMClinicalReview #DiabetesTreatment #BloodSugarControl #PBF #PBM #WeightManagement #HeartHealth #PharmacyBenefitManagement
To view or add a comment, sign in
-
9/10 patients prefer CeQur Simplicity!* Talk to your patients about CeQur Simplicity. myceqursimplicity.com *Zraick V, Dreon D, Nalk R, Shearer D, Crawford S, Bradford J, Levy B. 2016. Patient User Experience Evaluation of Bolus Patch Insulin Delivery System. Poster presented at the American Diabetes Association’s 76th Scientific Sessions. Abstract 995-P. New Orleans, LA, USA. #CeQurSimplicity #MealtimeInsulin #DiabetesManagement #InsulinDelivery #SimplifyDiabetes #Diabetes
To view or add a comment, sign in
-
🌟 On March 8, 2024, the United States FDA expanded approval of Wegovy (semaglutide), making it the first weight loss drug that is FDA-approved for obese and overweight patients at high risk for heart problems. The updated approval allows doctors to prescribe the drug for these patients to reduce the risk of cardiovascular death, heart attack, and stroke. However, the FDA notes that lifestyle changes, such as a healthy diet and increased physical activity, should accompany this drug. 💼🔍📈 #Wegovy #FDA #Healthcare #CardiovascularDisease #MedicalNews #Innovation #HealthTech #WeightLoss #HeartHealth #NewTreatment #MedicalResearch #HealthcareIndustry #ClinicalTrials #PublicHealth #HealthyLiving
To view or add a comment, sign in
-
Are you managing type 2 diabetes? Let Morgan Compounding Pharmacy introduce you to a game-changing alternative. Our transdermal metformin cream not only aids in diabetes management but also shows potential for dementia prevention, all without the common GI side effects. Learn more about this innovative approach in our latest blog. https://bit.ly/3TtbAGn #MetforminInnovation #DiabetesCare #AlpharettaGA #NorthFulton #Compounding #Pharmacy #CompoundingPharmacy #HealingJourney #Medication #FunctionalMedicine
To view or add a comment, sign in
-
Join us on May 10th as Dr. Sravanthi Madala, an Endocrinologist and eConsult Specialist, explores clinical factors to consider when determining the best strategy to improve glucose control in patients with type 2 diabetes and discusses new medications. Register here: https://hubs.ly/Q02vzYr00 #webinar #diabetes #econsults
To view or add a comment, sign in
-
Multi-center, open label, randomized control trial showed glycemic improvements were reproduced and sustained on the #MiniMed780G system vs. the standard of care, supporting early adoption of AID therapy in people with type 1 diabetes not meeting glucose targets on MDI therapy. Learn More: https://lnkd.in/gx6TAAxc #MedtronicDiabetes #RethinkingDiabetesCare #MiniMed780G MiniMed™ 780G system is for type 1 ages 7 and over. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day. For details, see https://bit.ly/780gRisks Due to inherent study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.
To view or add a comment, sign in
-
Senior in timpview who is interested in healthcare field, loves biology and anatomy. Would love to learn and experience anywhere related to health profession, loves to serve people in any way.
Today, the pharmacist and I discussed one of the most common things dealt with in pharmacy, insulin. Many people are diagnosed with diabetes every year, making it the most common chronic illness in the United States. The only way to suppress the symptoms of diabetes is insulin. The pharmacist and I have discussed deeper into how insulin works in the body the side effects of this wonderful medicine and how pharmacy plays a role in treating people with diabetes.
To view or add a comment, sign in
9,292 followers